Financial Ratios

WANBURY LTD.

NSE : WANBURYBSE : 524212ISIN CODE : INE107F01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE151.902.1 (+1.4 %)
PREV CLOSE ( ) 149.80
OPEN PRICE ( ) 144.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25594
TODAY'S LOW / HIGH ( )142.50 154.05
52 WK LOW / HIGH ( )35.95 177.4
NSE152.003.75 (+2.53 %)
PREV CLOSE( ) 148.25
OPEN PRICE ( ) 148.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 152.00 (632)
VOLUME 189362
TODAY'S LOW / HIGH( ) 142.60 154.75
52 WK LOW / HIGH ( )35.1 179.35
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-3.1824.94-5.0425.79-10.48
   CEPS(Rs)0.6128.45-1.1429.66-6.27
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-2.750.29-52.37-47.23-77.49
   Tax Rate(%)-1.06-0.43-1.610.320.55
Margin Ratios
   Core EBITDA Margin(%)4.536.173.97-5.833.21
   EBIT Margin(%)2.1819.772.7126.303.58
   Pre Tax Margin(%)-2.0215.77-3.1517.44-6.01
   PAT Margin (%)-2.0415.83-3.2017.38-5.98
   Cash Profit Margin (%)0.3918.06-0.7219.99-3.58
Performance Ratios
   ROA(%)-3.2425.97-4.5423.23-9.05
   ROE(%)0.000.000.000.000.00
   ROCE(%)17.68206.2628.24204.9126.93
   Asset Turnover(x)1.591.641.421.341.51
   Sales/Fixed Asset(x)2.182.321.881.832.08
   Working Capital/Sales(x)-2.95-3.16-1.70-1.93-1.75
Efficiency Ratios
   Fixed Capital/Sales(x)0.460.430.530.550.48
   Receivable days46.8734.5039.4546.8532.42
   Inventory Days25.7026.4517.1715.5414.22
   Payable days197.24189.83209.99242.15180.88
Valuation Parameters
   PER(x)0.003.410.000.710.00
   PCE(x)61.382.99-72.770.61-3.48
   Price/Book(x)-13.55296.26-1.58-0.39-0.28
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.360.620.910.520.71
   EV/Core EBITDA(x)7.578.6717.447.8311.24
   EV/EBIT(x)16.413.1433.391.9718.77
   EV/CE(x)0.610.921.260.700.99
   M Cap / Sales0.240.540.530.120.13
Growth Ratio
   Net Sales Growth(%)-2.2630.236.82-6.115.46
   Core EBITDA Growth(%)-34.5980.29-16.93-1.14182.59
   EBIT Growth(%)-89.08853.58-89.06554.701091.86
   PAT Growth(%)-112.76746.33-119.56359.4122.32
   EPS Growth(%)-112.74594.95-119.54346.1822.32
Financial Stability Ratios
   Total Debt/Equity(x)-7.1271.51-1.22-1.39-1.27
   Current Ratio(x)0.410.510.290.320.29
   Quick Ratio(x)0.340.360.220.280.23
   Interest Cover(x)0.524.940.462.970.37
   Total Debt/Mcap(x)0.530.240.773.604.50

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.